Once-Weekly Semaglutide in Adults with Overweight or Obesity
Evidence Based Medicine presented by InpharmD™ · InpharmD™
July 2, 20217m 38s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
An international, randomized, double-blind, placebo-controlled trial conducted to evaluate the efficacy and safety of semaglutide, as compared with placebo, as an adjunct to lifestyle intervention for reducing body weight in overweight and obese adults without diabetes.